Pacira reported $-1927000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Astellas Pharma JPY 90.42B 29.86B Jun/2025
Bristol-Myers Squibb USD 1.77B 1.2B Jun/2025
Ironwood Pharmaceuticals USD 17.37M 4.14M Sep/2024
J&J USD 13.63B 8.21B Mar/2025
Ligand Pharmaceuticals USD 39.14M 89.32M Jun/2025
Novo Nordisk 33.8B 3.23B Jun/2025
Pacira USD -1927000 10.63M Jun/2025
Perrigo USD 3.2M 5.1M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Supernus Pharmaceuticals USD 16.67M 22.5M Jun/2025
Teva Pharmaceutical Industries USD 203M 91M Jun/2025
Xeris Pharmaceuticals USD -1930000 3.18M Jun/2025
Zoetis USD 902M 92M Jun/2025